Biolexis Therapeutics Advances GLP-1 Receptor Activation with AI

Mar 15, 2025
Biolexis Therapeutics has confirmed a novel allosteric activation mechanism for the GLP-1 receptor using its AI-driven platform, MolecuLern, as announced in a press release.
Biolexis Therapeutics Advances GLP-1 Receptor Activation with AI

Biolexis Therapeutics has confirmed a novel allosteric activation mechanism for the GLP-1 receptor using its AI-driven platform, MolecuLern, announced in a press release. The company achieved this milestone through the cryo-electron microscopy (cryoEM) structure resolution of BLX-7006, a first-in-class oral small-molecule GLP-1 receptor agonist.

The cryoEM structural confirmation validates the predictive capabilities of MolecuLern, which identified BLX-7006 as a novel small molecule capable of allosterically modulating GLP-1 receptor activity. Unlike other oral small-molecule GLP-1 therapies, BLX-7006 is a brand-new chemotype with a unique binding mode.

Biolexis is currently completing the necessary toxicology and manufacturing studies to support human clinical testing of BLX-7006, with plans to initiate first-in-human trials in Q3 2025. This marks a significant step toward providing new therapeutic options for patients with obesity, type 2 diabetes, and metabolic dysfunction.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.